Mmp12 deficiency attenuated AAA development allied with reduced macrophage recruitment in the peri-aortic CaCl2-application model (122), and a mouse model of combined Ang II-infusion and TGF-β neutralising antibody treatment (66). This evidence concerns the gene TGFB1 and triple-A syndrome.